NCI, FDA Announce Two New Initiatives As Part of Strategic Partnership
Thursday, December 11th, 2003At a Friends of Cancer Research meeting, National Cancer Institute (NCI) Director Andrew C. von Eschenbach, M.D., and Food and Drug Administration (FDA) Commissioner Mark McClellan, M.D., Ph.D, announced two new collaborative initiatives to facilitate the development and use of better cancer treatments. The initiatives include a new system for submitting investigational new drug (IND) […]
Loading ...